ALX Oncology Holdings, Inc. (ALXO)
2.02
+0.03
(+1.51%)
USD |
NASDAQ |
Aug 25, 10:27
ALX Oncology Holdings 1 Year Total Returns (Daily) : 70.09% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 70.09% |
| August 21, 2026 | 98.06% |
| August 20, 2026 | 139.2% |
| August 19, 2026 | 131.6% |
| August 18, 2026 | 114.2% |
| August 17, 2026 | 205.8% |
| August 14, 2026 | 199.2% |
| August 13, 2026 | 193.7% |
| August 12, 2026 | 226.8% |
| August 11, 2026 | 214.1% |
| August 10, 2026 | 204.4% |
| August 07, 2026 | 198.0% |
| August 06, 2026 | 201.0% |
| August 05, 2026 | 190.4% |
| August 04, 2026 | 235.8% |
| August 03, 2026 | 272.5% |
| July 31, 2026 | 241.9% |
| July 30, 2026 | 226.6% |
| July 29, 2026 | 235.3% |
| July 28, 2026 | 217.9% |
| July 27, 2026 | 283.9% |
| July 24, 2026 | 275.9% |
| July 23, 2026 | 299.1% |
| July 22, 2026 | 320.9% |
| July 21, 2026 | 327.1% |
| Date | Value |
|---|---|
| July 20, 2026 | 279.0% |
| July 17, 2026 | 326.8% |
| July 16, 2026 | 343.3% |
| July 15, 2026 | 335.2% |
| July 14, 2026 | 326.6% |
| July 13, 2026 | 308.3% |
| July 10, 2026 | 327.6% |
| July 09, 2026 | 311.8% |
| July 08, 2026 | 408.0% |
| July 07, 2026 | 431.5% |
| July 06, 2026 | 376.0% |
| July 02, 2026 | 365.2% |
| July 01, 2026 | 375.4% |
| June 30, 2026 | 398.7% |
| June 29, 2026 | 442.1% |
| June 26, 2026 | 350.7% |
| June 25, 2026 | 291.1% |
| June 24, 2026 | 293.3% |
| June 23, 2026 | 282.9% |
| June 22, 2026 | 236.8% |
| June 18, 2026 | 214.5% |
| June 17, 2026 | 192.8% |
| June 16, 2026 | 159.6% |
| June 15, 2026 | 208.4% |
| June 12, 2026 | 192.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 306.6% |
| Oncolytics Biotech, Inc. | -16.43% |
| Sangamo Therapeutics, Inc. | -72.71% |
| Sarepta Therapeutics, Inc. | -10.34% |
| Anixa Biosciences, Inc. | 18.30% |